AGM – Gene Therapy for Leukodystrophy

There is currently very little research into white matter diseases in Australia. This has changed when Associate Professor Matthias Klugmann and his team started their work in the Translational Neuroscience Facility at the University of New South Wales (UNSW) in 2010. Since then Matthias was awarded a prestigious Future Fellowship by the Australian Research Council (ARC) for his research program on the role of a major brain metabolite in the etiology of leukodystrophies. More good news followed...

December 17th, 2012 | Categories: Articles, Conferences

ALDS June 2012 Newsletter

June 2012 Newsletter

June 19th, 2012 | Categories: Articles, News, Newsletter